Home › Funds › Nearwater Capital Markets, Ltd › NBIX

Nearwater Capital Markets, Ltd position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

Nearwater Capital Markets, Ltd reported holding 155,000 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 0.50% of its reported portfolio and ranking #46 among its reported holdings. Nearwater Capital Markets, Ltd has disclosed NBIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)155.00K sh
Reported value held$21.99M
Portfolio Weight0.50%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Nearwater Capital Markets, Ltd's NBIX position evolved

Nearwater Capital Markets, Ltd first disclosed a stake in NBIX in Q2 2026 at 155,000 shares (US$26.1M). Across 2 filings, Nearwater Capital Markets, Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 155,000 shares valued at US$22.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 155.00K $26.12M New
Q3 2026 155.00K $21.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 29 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M), RTW INVESTMENTS, LP (US$133.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has Nearwater Capital Markets, Ltd held NBIX?

Nearwater Capital Markets, Ltd has disclosed NBIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Nearwater Capital Markets, Ltd's current position in NBIX?

As of Q3 2026, Nearwater Capital Markets, Ltd holds 155.00K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $21.99M, representing 0.50% of its reported portfolio and ranking #46.

Has Nearwater Capital Markets, Ltd been buying or selling NBIX?

In the latest 13F filing (Q3 2026), Nearwater Capital Markets, Ltd held unchanged its position in NBIX.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Renaissance Technologies, Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.